The analysis of pharmacovigilance for a drug, utilizing postmarketing safety databases like the FAERS, plays a crucial role in the ongoing management of risks by detecting safety signals that may not have been identified during the drugs clinical development phase [Reference Anand, Ensor, Trachtenberg and Bernicker10, Reference Jedlowski, Jedlowski and Fazel14, Reference Egeberg and Thyssen32Reference Yu, Krantz, Phillips and Stone35]
Efficacy Comparison: Weight Loss and Blood Sugar Control GLP 1 medications show meaningful differences in their glucose lowering and weight reducing effects
Antioxidants (Basel) 10, 186
9 There is a need for further longitudinal studies to confirm safety, which may slow adoption in broader patient populations
And then later were finding all these slew of other benefits that no one would have predicted
GHK-Cu turns on collagen production at the gene level and clears damaged tissue in parallel